The global prefilled syringe (PFS) market was estimated at $7.22 billion in 2022 and is forecast to grow to $16.32 billion by 2030. The use of PFSs to administer biotherapeutics is beginning to gain traction because they offer a range of stability, efficacy, and patient safety benefits. Lonza has used advanced testing capabilities to assess the factors that could impact injection force and developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors.
Please check the highlighted fields and try again.
Please fill out the information below. If you are already registered, login and this information will be filled out for you.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the phone number you would like to be contacted at.
Please enter the e-mail address you would like to be contacted at.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.